Sjogren's syndrome: from pathogenesis to novel therapeutic targets

被引:0
作者
Barone, F. [1 ]
Colafrancesco, S. [1 ,2 ]
机构
[1] Univ Birmingham, Ctr Translat Inflammat Res, Inst Inflammat & Ageing, Birmingham B15 2TT, W Midlands, England
[2] Sapienza Univ Rome, Dept Internal Med & Med Specialties, Rheumatol Unit, Rome, Italy
基金
英国医学研究理事会;
关键词
primary Sjogren's syndrome; biologics; TLOs; stromal cells; chemokines; cytokines; FIBROBLASTIC RETICULAR CELLS; TUMOR-NECROSIS-FACTOR; QUALITY-OF-LIFE; LYMPH-NODE; SALIVARY-GLANDS; B-CELLS; MALIGNANT-LYMPHOMA; CIRCULATING LEVELS; GERMINAL-CENTERS; MALT LYMPHOMA;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Primary Sjogren's syndrome (pSS) is a chronic inflammatory autoimmune disease, characterised by a chronic infiltration of exocrine glands, mainly salivary glands, with the histological features of focal lymphocytic sialoadenitis. Disease spectrum is broad and the occurrence of several extra-glandular manifestations, and in rare cases lymphoma development, is well known. A specific approved treatment for pSS is still lacking and the detection of novel therapeutic biologic target is ongoing. The identification of biological fingerprints seems essential in order to stratify patients both in clinical trials and in real life. Discovery of new components of the inflammatory response will be the key in the future for the identification of novel additional therapeutic options.
引用
收藏
页码:S58 / S62
页数:5
相关论文
共 64 条
[11]   Increased circulating levels and salivary gland expression of interleukin-18 in patients with Sjogren's syndrome: relationship with autoantibody production and lymphoid organization of the periductal inflammatory infiltrate [J].
Bombardieri, M ;
Barone, F ;
Pittoni, V ;
Alessandri, C ;
Conigliaro, P ;
Blades, MC ;
Priori, R ;
McInnes, IB ;
Valesini, G ;
Pitzalis, C .
ARTHRITIS RESEARCH & THERAPY, 2004, 6 (05) :R447-R456
[12]   Activation-induced cytidine deaminase expression in follicular dendritic cell networks and interfollicular large B cells supports functionality of ectopic lymphoid neogenesis in autoimmune sialoadenitis and MALT lymphoma in Sjogren's syndrome [J].
Bombardieri, Michele ;
Barone, Francesca ;
Humby, Frances ;
Kelly, Stephen ;
McGurk, Mark ;
Morgan, Peter ;
Challacombe, Stephen ;
De Vita, Salvatore ;
Valesini, Guido ;
Spencer, Jo ;
Pitzalis, Costantino .
JOURNAL OF IMMUNOLOGY, 2007, 179 (07) :4929-4938
[13]   Interleukin-18 as a potential therapeutic target in chronic autoimmune/inflammatory conditions [J].
Bombardieri, Michele ;
McInnes, Iain B. ;
Pitzalis, Costantino .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2007, 7 (01) :31-40
[14]  
BOUMBA D, 1995, BRIT J RHEUMATOL, V34, P326
[15]   Estimating Indirect Costs in Primary Sjogren's Syndrome [J].
Bowman, Simon J. ;
Pierre, Yvan St. ;
Sutcliffe, Nurhan ;
Isenberg, David A. ;
Goldblatt, Fiona ;
Price, Elizabeth ;
Hamburger, John ;
Richards, Andrea ;
Rauz, Saaeha ;
Regan, Marian ;
Rigby, Shirley ;
Jones, Adrian ;
Mulherin, Diarmuid ;
Clarke, Ann E. .
JOURNAL OF RHEUMATOLOGY, 2010, 37 (05) :1010-1015
[16]  
Brennan MT, 1999, J RHEUMATOL, V26, P2373
[17]   Prognosis of patients with primary Sjogren's syndrome [J].
Brito-Zeron, Pilar ;
Ramos-Casals, Manuel .
MEDICINA CLINICA, 2008, 130 (03) :109-115
[18]   Prevalence and Clinical Relevance of Autoimmune Neutropenia in Patients with Primary Sjogren's Syndrome [J].
Brito-Zeron, Pilar ;
Soria, Natalia ;
Munoz, Sandra ;
Bove, Albert ;
Akasbi, Miriam ;
Belenguer, Rafael ;
Siso, Antoni ;
Ramos-Casals, Manttel .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2009, 38 (05) :389-395
[19]   Stromal Cells in Chronic Inflammation and Tertiary Lymphoid Organ Formation [J].
Buckley, Christopher D. ;
Barone, Francesca ;
Nayar, Saba ;
Benezech, Cecile ;
Caamano, Jorge .
ANNUAL REVIEW OF IMMUNOLOGY VOL 33, 2015, 33 :715-745
[20]   Direct healthcare costs and predictors of costs in patients with primary Sjogren's syndrome [J].
Callaghan, R. ;
Prabu, A. ;
Allan, R. B. ;
Clarke, A. E. ;
Sutcliffe, N. ;
Pierre, Yvan St. ;
Gordon, C. ;
Bowman, S. J. .
RHEUMATOLOGY, 2007, 46 (01) :105-111